Statistics for Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer
Total visits
views | |
---|---|
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer | 2 |
Total visits per month
views | |
---|---|
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 1 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
java.util.UUID:8c34c1be-5d65-4ace-98b2-16c22939fdac | 7 |
java.util.UUID:c9f6e0c2-7a47-4290-9ad0-de61cee0077b | 4 |
Lheureux2022Translational-CCBY.pdf | 2 |
java.util.UUID:fd96c24c-3e72-4ed8-98c7-925a339bcdc4 | 2 |
Top country views
views | |
---|---|
United States | 2 |
Top city views
views | |
---|---|
Franklin | 1 |
Indianapolis | 1 |